HSDT
Helius Medical Technologies Inc Class A
2.60$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -632,128.50 | -793,741.20 | -793,741.20 | -1,360,915.49 | -1,130,241.94 | -1,045,766.93 | -367,501.57 | -204,365.75 | -39,758.84 | -12,851.01 | -3,055.88 | -0.75 | |
| 1,700.00 | 1,700.00 | 1,700.00 | 1,197.18 | 3,398.62 | 9,511.95 | 15,090.80 | 5,709.05 | 850.19 | 199.87 | 16.61 | 0.03 | |
| 139,711.40 | 123,125.00 | 146,200.00 | 128,028.17 | 466,301.84 | 233,615.54 | 79,179.71 | 64,906.12 | 6,262.50 | 2,009.82 | 698.03 | 0.42 | |
| 308,025.10 | -121,161.80 | 491,668.00 | 482,112.68 | 573,790.32 | -454,780.88 | 93,362.55 | 65,715.16 | 2,258.84 | – | – | – | |
| 26,029.30 | 15,601.80 | 15,601.80 | 129,295.77 | -58,640.55 | -113,396.41 | -31,809.64 | 1,938.64 | -3,628.58 | -383.70 | -2.21 | 0.01 | |
| 632,128.50 | 19,000.00 | 793,741.20 | 13,380.28 | 25,345.62 | 13,844.62 | 1,972.45 | 824.30 | 47.23 | 35.78 | 1.38 | 2.03 | |
| -37,800.00 | 37,800.00 | 37,800.00 | -13,380.28 | -25,345.62 | -38,296.81 | -281.78 | -854.83 | -30.56 | -35.78 | -1.38 | -19.35 | |
| 663,720.30 | 769,134.00 | 950,551.00 | 1,652,535.21 | 2,305,760.37 | 82,320.72 | 301,753.29 | – | – | – | – | – | |
| 63,207.60 | 200,000.00 | – | – | – | – | – | 0.00 | – | – | 0.00 | -0.03 | |
| 748,272.80 | 969,133.60 | 969,133.60 | 1,564,647.89 | 2,305,760.37 | 82,320.72 | 301,753.29 | 322,485.12 | 49,647.14 | 1,328.78 | 1,924.69 | 20.38 | |
| 40,292.50 | 222,504.40 | 222,504.40 | 205,497.39 | 1,153,283.41 | -1,002,191.24 | -66,624.92 | 117,142.42 | 9,846.63 | -11,556.78 | -1,133.12 | 0.28 | |
| -632,128.50 | -793,741.20 | -788,500.00 | -1,374,295.77 | -1,155,587.56 | -1,059,611.55 | -369,474.01 | -205,190.05 | -39,806.07 | -12,886.79 | -3,057.26 | -2.78 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.